A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

被引：0
|
作者：
Nong Xu
Xiao Chen Zhang
Jian Ping Xiong
Wei Jia Fang
Lan Fang Yu
Jiong Qian
Ling Zhang
机构：
[1] Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
[2] Nanchang University,Department of Oncology, The First Affiliated Hospital
来源：
BMC Cancer | / 7卷
关键词：
Bone Metastasis; Carboplatin; Transitional Cell Carcinoma; Overall Response Rate; Eastern Cooperative Oncology Group Performance Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract -: An alternative therapy
    Nogué-Aliguer, M
    Carles, J
    Arrivi, A
    Juan, O
    Alonso, L
    Font, A
    Mellado, B
    Garrido, P
    Sáenz, A
    CANCER, 2003, 97 (09) : 2180 - 2186
  • [42] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder COMMENT
    Tagawa, Scott T.
    JOURNAL OF UROLOGY, 2008, 180 (06): : 2388 - 2388
  • [43] Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder
    Chun, R
    Knapp, DW
    Widmer, WR
    DeNicola, DB
    Glickman, NW
    Kuczek, T
    Degortari, A
    Han, CM
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1997, 11 (05) : 279 - 283
  • [44] Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium
    Meluch, A. A.
    Burris, H. S.
    Greco, F. A.
    Hainsworth, J. D.
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S30 - S33
  • [45] Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Mazumdar, M
    Russo, P
    Sheinfeld, J
    Donat, SM
    Bochner, BH
    Herr, HW
    Sogani, P
    Ginty, J
    Bajorin, DF
    JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72
  • [46] Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium
    Hoschke, B
    May, M
    Seehafer, M
    Helke, C
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (07) : 461 - 466
  • [47] Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer
    Edelman, MJ
    Smith, R
    Hausner, P
    Doyle, LA
    Kalra, K
    Kendall, J
    Bedor, M
    Bisaccia, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5774 - 5778
  • [48] Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Locally Advanced and Metastatic Nonclear Cell Renal Cell Carcinoma
    Richey, Stephen L.
    Tamboli, Pheroze
    Ng, Chaan S.
    Lin, E.
    Lim, Zita D.
    Araujo, John C.
    Jonasch, Eric
    Sharma, Padmanee
    Pagliaro, Lance C.
    Tannir, Nizar M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 450 - 454
  • [49] Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer
    Johannsen, M
    Sachs, M
    Roigas, J
    Hinke, A
    Staack, A
    Loening, SA
    Schnorr, D
    Wille, AH
    EUROPEAN UROLOGY, 2005, 48 (02) : 246 - 251
  • [50] Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma
    Hurwitz, Michael E.
    Markowski, Paul
    Yao, Xiaopan
    Deshpande, Hari
    Patel, Jaymin
    Mortazavi, Amir
    Donadio, Alessia
    Stein, Mark N.
    Kelly, William Kevin
    Petrylak, Daniel Peter
    Mehnert, Janice M.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : 437 - +
12345